Anbio Biotechnology Announces IPO Details
Ticker: NNNN · Form: 6-K · Filed: Feb 21, 2025 · CIK: 1982708
| Field | Detail |
|---|---|
| Company | Anbio Biotechnology (NNNN) |
| Form Type | 6-K |
| Filed Date | Feb 21, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: ipo, underwriting-agreement, shares
TL;DR
Anbio Biotech is selling 1.6M shares in an IPO to AC Sunshine Securities.
AI Summary
Anbio Biotechnology, a Cayman Islands exempted company, announced on February 18, 2025, its initial public offering (IPO). The company agreed to sell 1,600,000 Class A ordinary shares at a par value of $0.0001 per share to AC Sunshine Securities LLC., acting as the representative of the underwriters.
Why It Matters
This filing details the terms of Anbio Biotechnology's initial public offering, providing insight into the company's strategy for raising capital and expanding its market presence.
Risk Assessment
Risk Level: medium — The company is undergoing an IPO, which inherently carries risks related to market reception and valuation, and the filing does not provide extensive financial details beyond the share offering.
Key Numbers
- 1,600,000 — Class A Ordinary Shares (Number of shares to be sold in the IPO)
Key Players & Entities
- Anbio Biotechnology (company) — Filer of the report and issuer of shares
- AC Sunshine Securities LLC. (company) — Representative of the underwriters for the IPO
- 1,600,000 (dollar_amount) — Number of Class A ordinary shares to be sold in the IPO
- February 18, 2025 (date) — Date of the underwriting agreement
FAQ
What is the total number of Class A ordinary shares Anbio Biotechnology has agreed to sell in its IPO?
Anbio Biotechnology has agreed to sell an aggregate of 1,600,000 Class A ordinary shares.
Who is the representative of the underwriters for Anbio Biotechnology's IPO?
AC Sunshine Securities LLC. is the representative of the underwriters.
On what date was the underwriting agreement for the IPO entered into?
The underwriting agreement was entered into on February 18, 2025.
What is the par value of the Class A ordinary shares being offered?
The par value of the Class A ordinary shares is $0.0001 per share.
What type of company is Anbio Biotechnology?
Anbio Biotechnology is a Cayman Islands exempted company.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on February 21, 2025 regarding Anbio Biotechnology (NNNN).